Enveric Biosciences (ENVB) Competitors $1.23 -0.05 (-3.91%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$1.23 0.00 (0.00%) As of 06/11/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ENVB vs. INAB, CLRB, UBX, CSCI, TRIB, RLYB, BCDA, BGXX, CLDI, and ATHAShould you be buying Enveric Biosciences stock or one of its competitors? The main competitors of Enveric Biosciences include IN8bio (INAB), Cellectar Biosciences (CLRB), Unity Biotechnology (UBX), COSCIENS Biopharma (CSCI), Trinity Biotech (TRIB), Rallybio (RLYB), BioCardia (BCDA), Bright Green (BGXX), Calidi Biotherapeutics (CLDI), and Athira Pharma (ATHA). These companies are all part of the "pharmaceutical products" industry. Enveric Biosciences vs. Its Competitors IN8bio Cellectar Biosciences Unity Biotechnology COSCIENS Biopharma Trinity Biotech Rallybio BioCardia Bright Green Calidi Biotherapeutics Athira Pharma IN8bio (NASDAQ:INAB) and Enveric Biosciences (NASDAQ:ENVB) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, community ranking, institutional ownership, earnings, media sentiment and analyst recommendations. Which has better earnings and valuation, INAB or ENVB? IN8bio is trading at a lower price-to-earnings ratio than Enveric Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIN8bioN/AN/A-$30.01M-$13.57-0.19Enveric BiosciencesN/AN/A-$17.29M-$38.38-0.03 Does the MarketBeat Community believe in INAB or ENVB? IN8bio received 20 more outperform votes than Enveric Biosciences when rated by MarketBeat users. Likewise, 72.22% of users gave IN8bio an outperform vote while only 60.00% of users gave Enveric Biosciences an outperform vote. CompanyUnderperformOutperformIN8bioOutperform Votes2672.22% Underperform Votes1027.78% Enveric BiosciencesOutperform Votes660.00% Underperform Votes440.00% Which has more risk and volatility, INAB or ENVB? IN8bio has a beta of 0.18, meaning that its share price is 82% less volatile than the S&P 500. Comparatively, Enveric Biosciences has a beta of 0.53, meaning that its share price is 47% less volatile than the S&P 500. Does the media refer more to INAB or ENVB? In the previous week, IN8bio had 6 more articles in the media than Enveric Biosciences. MarketBeat recorded 9 mentions for IN8bio and 3 mentions for Enveric Biosciences. IN8bio's average media sentiment score of 0.39 beat Enveric Biosciences' score of 0.29 indicating that IN8bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IN8bio 0 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Enveric Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate INAB or ENVB? IN8bio currently has a consensus target price of $180.00, suggesting a potential upside of 6,986.61%. Enveric Biosciences has a consensus target price of $10.00, suggesting a potential upside of 713.01%. Given IN8bio's higher possible upside, equities research analysts plainly believe IN8bio is more favorable than Enveric Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IN8bio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Enveric Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is INAB or ENVB more profitable? IN8bio's return on equity of -197.15% beat Enveric Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets IN8bioN/A -197.15% -130.48% Enveric Biosciences N/A -221.54%-164.32% Do institutionals and insiders hold more shares of INAB or ENVB? 92.1% of IN8bio shares are owned by institutional investors. Comparatively, 13.8% of Enveric Biosciences shares are owned by institutional investors. 15.5% of IN8bio shares are owned by company insiders. Comparatively, 1.1% of Enveric Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryIN8bio beats Enveric Biosciences on 10 of the 13 factors compared between the two stocks. Get Enveric Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ENVB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ENVB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ENVB vs. The Competition Export to ExcelMetricEnveric BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.04M$6.85B$5.57B$8.62BDividend YieldN/A2.56%5.28%4.18%P/E Ratio-0.038.7827.1720.06Price / SalesN/A255.64409.72157.10Price / CashN/A65.8538.2534.64Price / Book0.116.557.064.70Net Income-$17.29M$143.93M$3.23B$247.88M7 Day Performance-2.38%3.97%2.89%2.66%1 Month Performance-9.23%11.32%9.06%6.40%1 Year Performance-89.22%4.20%31.40%14.07% Enveric Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ENVBEnveric Biosciences2.2189 of 5 stars$1.23-3.9%$10.00+713.0%-88.9%$3.04MN/A-0.0320Short Interest ↑Gap DownINABIN8bio3.5497 of 5 stars$0.13-9.8%$6.00+4,387.7%-94.0%$12.14MN/A-0.1820Stock SplitShort Interest ↓Gap DownHigh Trading VolumeCLRBCellectar Biosciences2.5727 of 5 stars$0.26+2.8%$12.50+4,669.2%-86.9%$12.08MN/A-0.1510Short Interest ↓Gap UpUBXUnity Biotechnology4.265 of 5 stars$0.72+2.4%$3.75+423.5%-46.0%$12.04M$240K-0.5560Positive NewsGap UpCSCICOSCIENS BiopharmaN/A$3.81+13.2%N/AN/A$12.00M$9.03M-0.3220Positive NewsTRIBTrinity Biotech1.795 of 5 stars$0.66+2.7%N/A-75.9%$11.92M$61.56M-0.29480Positive NewsUpcoming EarningsRLYBRallybio3.202 of 5 stars$0.29-7.4%$10.00+3,394.1%-78.3%$11.91M$848K-0.1840Positive NewsGap DownHigh Trading VolumeBCDABioCardia3.7744 of 5 stars$2.26+4.6%$25.00+1,006.2%-38.2%$11.70M$3K-0.5440Positive NewsShort Interest ↓Gap UpBGXXBright GreenN/AN/AN/AN/A$11.47MN/A-1.002Gap DownCLDICalidi Biotherapeutics1.5111 of 5 stars$0.35-1.2%$10.00+2,790.2%N/A$11.14M$50K0.0038Gap UpHigh Trading VolumeATHAAthira Pharma2.8851 of 5 stars$0.29-8.8%$13.83+4,752.1%-87.4%$11.13MN/A-0.1040Gap Down Related Companies and Tools Related Companies INAB Alternatives CLRB Alternatives UBX Alternatives CSCI Alternatives TRIB Alternatives RLYB Alternatives BCDA Alternatives BGXX Alternatives CLDI Alternatives ATHA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ENVB) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enveric Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enveric Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ENVB Stock Free ENVB Stock Alerts